Skip to main content
OpenTrials

Clinical trial condition

Lung Neoplasms

Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.

4,211 public trials 1,007 recruiting studies
Refine in advanced search Browse all conditions

Lung Neoplasms trial results

Active, Not Recruiting

Avelumab Program Rollover Study

NCT03815643

Conditions
Adenocarcinoma, Adnexal Diseases, Bronchial Neoplasms, +32 more
Locations
  • HonorHealth Research Institute Scottsdale, Arizona, United States
  • Highlands Oncology Group Fayetteville, Arkansas, United States
  • University of California Davis Health System - Comprehensive Cancer Center Sacramento, California, United States
  • Providence Medical Foundation Santa Rosa, California, United States
View all 104 locations
View Trial Details
Active, Not Recruiting

Observational Lung Trial to Collect Tissue to Train and Validate a Live Tumor Diagnostic Platform (ELEPHAS-01)

NCT05478538

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • UCLA Medical Center Los Angeles, California, United States
  • James M Stockman Cancer Institute Frederick, Maryland, United States
  • New York Cancer & Blood Specialists Shirley, New York, United States
  • University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
View Trial Details
Active, Not Recruiting

A Phase III, Open-Label Study of Maintenance Lurbinectedin in Combination With Atezolizumab Compared With Atezolizumab in Participants With Extensive-Stage Small-Cell Lung Cancer

NCT05091567

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • Northwest Georgia Oncology Centers, a Service of WellStar Cobb Hospital Marietta, Georgia, United States
  • Illinois Cancer Care Peoria, Illinois, United States
  • New England Cancer Specialists Scarborough, Maine, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View all 95 locations
View Trial Details
Active, Not Recruiting

Study of Pembrolizumab/Vibostolimab (MK-7684A) in Combination With Concurrent Chemoradiotherapy Followed by Pembrolizumab/Vibostolimab Versus Concurrent Chemoradiotherapy Followed by Durvalumab in Participants With Stage III Non-small Cell Lung Cancer (MK-7684A-006)

NCT05298423

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • VA Long Beach Healthcare System ( Site 2831) Long Beach, California, United States
  • VA West Los Angeles Medical Center ( Site 2808) Los Angeles, California, United States
  • Millennium Oncology Research Clinic ( Site 2801) Hollywood, Florida, United States
  • Mid Florida Hematology and Oncology Center ( Site 2800) Orange City, Florida, United States
View all 160 locations
View Trial Details
Active, Not Recruiting

First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid Tumors

NCT05277051

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +49 more
Locations
  • GSK Investigational Site San Francisco, California, United States
  • GSK Investigational Site Charlotte, North Carolina, United States
  • GSK Investigational Site Oklahoma City, Oklahoma, United States
  • GSK Investigational Site Philadelphia, Pennsylvania, United States
View all 26 locations
View Trial Details
Active, Not Recruiting

Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab With or Without Platinum Chemotherapy in 1L Non-Small Cell Lung Cancer (TROPION-Lung07)

NCT05555732

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Southern Cancer Center Pc Daphne, Alabama, United States
  • Ironwood Cancer and Research Centers Chandler, Arizona, United States
  • Arizona Oncology Associates, Pc - Nahoa Prescott Valley, Arizona, United States
  • Hoag Memorial Hospital Prebyterian Newport Beach, California, United States
View all 260 locations
View Trial Details

Related conditions